MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer (Q33570512)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer |
scientific article |
Statements
1 reference
MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer (English)
1 reference
George Fountzilas
1 reference
Ralph M Wirtz
1 reference
Vassiliki Kotoula
1 reference
Konstantine T Kalogeras
1 reference
Anna Kalogera-Fountzila
1 reference
Angelos Nikolaou
1 reference
Georgia Karayannopoulou
1 reference
Gerasimos Aravantinos
1 reference
Sophia Lambaki
1 reference
Samuel Murray
1 reference
Alexandros Lambropoulos
1 reference
Eleni Athanassiou
1 reference
Despina Misailidou
1 reference
Demosthenis Skarlos
1 reference
29 December 2009
1 reference
1 reference
2009
1 reference
305908
1 reference
1 January 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference